Multiple Sclerosis

Multiple Sclerosis (MS), a chronic autoimmune disease affecting the central nervous system, can have profound psychiatric implications. From mood disturbances to cognitive challenges, understanding the broader impact of MS is vital. The Journal of Clinical Psychiatry offers insights into the psychiatric aspects of MS, emphasizing evidence-based therapeutic approaches. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care to individuals with MS.

Page 13

Recently published articles about Multiple Sclerosis

JCP
Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials
JCP
The Patient Perspective on Tardive Dyskinesia
PCC
Diphenhydramine and Dextromethorphan Overdose
PCC
Catatonia, Neurocognitive Disorders, and End-of-Life Care
JCP
SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine Treatment
PCC
Antidepressant Monitoring Referrals to Higher-Level Services